Hannover, Germany

Wolf-Georg Forssmann

USPTO Granted Patents = 39 

 

 

Average Co-Inventor Count = 3.0

ph-index = 9

Forward Citations = 248(Granted Patents)


Location History:

  • Heidelberg DE (1995)
  • Heidelberg, DE (1988 - 1997)
  • Wies-Wambach, DE (2012)
  • Wles-Wambach, DE (2015)
  • Hannover, DE (1996 - 2019)
  • Hanover, DE (1998 - 2021)

Company Filing History:

goldMedal8 out of 8 
 
Pharis Biotec Gmbh
 patents
silverMedal4 out of 5 
 
Haemopep Pharma Gmbh
 patents
bronzeMedal3 out of 6 
 
Ipf Pharmaceuticals Gmbh
 patents
42 out of 3 
 
Organogen Medizinisch-molekularbiologische Forschungsgesellschaft M.b.h.
 patents
52 out of 2 
 
Cardiopep Pharma Gmbh
 patents
62 out of 2 
 
Pharma Bissendorf Peptide Gmbh
 patents
72 out of 2 
 
Pharis Biotech Gmbh
 patents
82 out of 2 
 
Uropep Biotech Gbr
 patents
92 out of 2 
 
Cardiorentis Ag
 patents
101 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents
111 out of 1 
 
Organon-medizinisch-molekularbiologische Forschungsgellschaft M.b.h
 patent
121 out of 4 
 
Biovision, Ag
 patents
131 out of 1 
 
Kabigen Ab and Skandigen Ab
 patent
141 out of 1 
 
Relaxera Pharma Gmbh & Co. Kg I.g.
 patent
151 out of 1 
 
Prof. Dr. Wolf-georg Forssmann
 patent
161 out of 1 
 
Neopep Pharma Gmbh. & Co.
 patent
171 out of 1 
 
Viro Pharmaceuticals Gmbh & Co. Kg
 patent
186 out of 832,761 
Other
 patents
where one patent can have more than one assignee

Years Active: 1988-2021

Loading Chart...
Loading Chart...
Loading Chart...
39 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Wolf-Georg Forssmann

Introduction

Wolf-Georg Forssmann is a prominent inventor based in Hannover, Germany, recognized for his significant contributions to the field of biomedicine. With an impressive portfolio of 39 patents, Forssmann has made groundbreaking advancements in the treatment of diseases through innovative peptide technologies.

Latest Patents

Among his latest patents, Forssmann has developed novel polypeptides designed for therapeutic applications. One notable invention is a polypeptide characterized by the general amino acid sequence ZIXRWXXKXPXXSZ. This polypeptide features specific modifications at both the N-terminal and C-terminal amino acids that enhance its therapeutic potential. Another critical patent focuses on peptides that exhibit antagonistic activities against the natural CXCR4 receptor, demonstrating effectiveness in blocking HIV-1 NL4-3 infection, with an impressive IC value of less than 50 µM.

Career Highlights

Throughout his career, Forssmann has been affiliated with various organizations, including Pharis Biotec GmbH, where he has contributed to pioneering research and development efforts in biomedical innovation. His expertise in peptide synthesis and application has been fundamental in advancing methodologies used in disease treatment and prevention.

Collaborations

Forssmann has collaborated with notable colleagues in the scientific community, including Ludger Ständker and Markus Meyer. These partnerships have fostered the exchange of ideas and expertise, enhancing the research capabilities within the field and leading to the successful development of innovative therapies.

Conclusion

In conclusion, Wolf-Georg Forssmann's extensive work in the development of peptides for medical applications underscores his role as a leading inventor in the biomedical landscape. His contributions have paved the way for advancements that could significantly improve therapeutic strategies for various diseases, showcasing the impact of innovation in science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…